Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Efficacy and safety of automated insulin delivery system in very young children with type 1 diabetes: A systematic review and meta-analysis of randomized controlled trials.

Diabetic medicine : a journal of the British Diabetic Association·2026

Same author

Impact of stepwise diabetes technology advances in older adults with type 1 diabetes: A systematic review and meta-analysis of randomised trials.

Diabetes, obesity & metabolism·2025

Same author

Efficacy and safety of a tubeless open-source hybrid automated insulin delivery use at home among adults with type 1 diabetes mellitus: Results from a 26-week, free-living, randomized crossover trial.

Diabetes, obesity & metabolism·2025

Same author

Pregnancy-Specific Glucose Management Index Predicts Preterm Birth and Pre-Eclampsia Superior to HbA1c in Women With Type 1 Diabetes Mellitus.

Diabetes/metabolism research and reviews·2025

Same author

Basal Hyperglycemia Contributes More Than 50% to Time in Range in Pregnant Women With Type 1 Diabetes.

The Journal of clinical endocrinology and metabolism·2024

Same author

Continuous subcutaneous insulin infusion versus multiple daily injection therapy in pregnant women with type 1 diabetes.

Journal of diabetes·2024

Same journal

Decoding fibrosis: Transcriptomic and clinical insights via AI-derived collagen deposition phenotypes in MASLD.

Hepatology (Baltimore, Md.)·2026

Same journal

A randomized controlled trial of stepped treatment to reduce unhealthy alcohol use in patients with chronic liver disease.

Hepatology (Baltimore, Md.)·2026

Same journal

AASLD AST NASPGHAN Practice Guideline on pediatric liver transplantation: Candidate evaluation.

Hepatology (Baltimore, Md.)·2026

Same journal

H4K12 lactylation drives TREM2high macrophages differentiation in liver fibrosis.

Hepatology (Baltimore, Md.)·2026

Same journal

Good vibrations: Using VCTE to predict hepatic decompensation in MASLD.

Hepatology (Baltimore, Md.)·2026

Same journal

One size does not fit all: Global variability in noninvasive testing for MASLD.

Hepatology (Baltimore, Md.)·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 29, 2026

Direct Restart of a Replication Fork Stalled by a Head-On RNA Polymerase

Direct Restart of a Replication Fork Stalled by a Head-On RNA Polymerase

Published on: April 29, 2010

Reply.

Jianping Weng¹

¹Department of Endocrinology, First Affiliated Hospital, Division of Life Sciences of Medicine, University of Science and Technology of China, Hefei, China.

Hepatology (Baltimore, Md.)

|February 8, 2019

Summary

This summary is machine-generated.

Nonalcoholic fatty liver disease (NAFLD) affects many with type 2 diabetes mellitus (T2DM). This study compared liraglutide, sitagliptin, and insulin glargine as add-on treatments for T2DM and NAFLD patients.

More Related Videos

Quaternary Structure Modeling Through Chemical Cross-Linking Mass Spectrometry: Extending TX-MS Jupyter Reports

Quaternary Structure Modeling Through Chemical Cross-Linking Mass Spectrometry: Extending TX-MS Jupyter Reports

Published on: October 20, 2021

Thermochemical Studies of NiII and ZnII Ternary Complexes Using Ion Mobility-Mass Spectrometry

Thermochemical Studies of NiII and ZnII Ternary Complexes Using Ion Mobility-Mass Spectrometry

Published on: June 8, 2022

Related Experiment Videos

Last Updated: Jan 29, 2026

Direct Restart of a Replication Fork Stalled by a Head-On RNA Polymerase

Direct Restart of a Replication Fork Stalled by a Head-On RNA Polymerase

Published on: April 29, 2010

Quaternary Structure Modeling Through Chemical Cross-Linking Mass Spectrometry: Extending TX-MS Jupyter Reports

Quaternary Structure Modeling Through Chemical Cross-Linking Mass Spectrometry: Extending TX-MS Jupyter Reports

Published on: October 20, 2021

Thermochemical Studies of NiII and ZnII Ternary Complexes Using Ion Mobility-Mass Spectrometry

Thermochemical Studies of NiII and ZnII Ternary Complexes Using Ion Mobility-Mass Spectrometry

Published on: June 8, 2022

Area of Science:

Hepatology
Endocrinology
Pharmacology

Background:

Nonalcoholic fatty liver disease (NAFLD) is common in type 2 diabetes mellitus (T2DM) patients.
Current guidelines lack approved pharmacotherapies for NAFLD.
Effective treatments for T2DM patients with NAFLD are needed.

Discussion:

This 26-week trial assessed liraglutide, sitagliptin, and insulin glargine as add-on therapies to metformin.
The study evaluated the efficacy and safety of these agents in T2DM patients with NAFLD.
Understanding treatment effects on NAFLD in T2DM is crucial for clinical practice.

Key Insights:

Liraglutide, sitagliptin, and insulin glargine were compared for T2DM and NAFLD.
The trial focused on add-on treatment to metformin.
Efficacy and safety data were collected over 26 weeks.

Outlook:

Further research may clarify optimal anti-diabetic agent selection for NAFLD.
This study contributes to evidence for managing NAFLD in T2DM.
Findings may inform future clinical practice guidelines.